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Summary Radiographically occult bronchogenic squamous cell carcinomas are early lung cancers that localize mainly in the bronchial wall,
and are thought to be a good model for investigating genetic alterations through lung cancer progression. In order to elucidate sequential
genetic changes in lung cancers, we analysed the incidence of allefic losses on chromosome regions 2q33, 3p21, 5q21, 7q31, 9p21 and
17p13 for 40 cases of radiographically occult bronchogenic squamous-cell carcinomas and 40 cases of advanced lung cancers
microdissected. In this study we used eight microsatellite dinucleotide polymorphic markers. Frequent loss of heterozygosity (LOH) was
observed on 3p21 (53%), 5q21 (44%) and 17p13 (61%) in roentgenographically occult bronchogenic squamous cell carcinomas. 2q, 7q and
9p were lost less frequently in both roentgenographically occult bronchogenic squamous cell carcinomas and advanced lung cancers. These
results suggest that several tumour-suppressor genes are associated with lung cancer progression and that genetic changes on 3p21, 5q21
and 17p13 are early events.
Keywords: radiographically occult bronchogenic squamous-cell carcinoma; loss of heterozygosity; microdissection; microsatellite
polymorphism; tumorigenesis
Rapid progress in molecular biology has made it clear that human
cancers develop through an accumulation of genetic changes. A
study of allelic losses is important to elucidate genetic alterations
and in the search for tumour-suppressor genes. Numerous reports
have been published concerning allelic losses in advanced lung
cancers (Tsuchiya et al. 1992: Field et al. 1996). The first report of
allelic losses in preneoplastic lesions ofthe lung was published by
Sundaresan et al (1992) and a few investigators have reported
allehic losses in early cancer or precancer ofthe lung in a few cases
(Chung et al. 1995: Hung et al. 1995: Thiberville et al. 1995a).
Therefore. forthe further elucidation ofmultistep tumorigenesis of
lutn cancer. more cases of early cancer or precancer of the lung
must be examined.
Radiographically occult bronchogenic squamous cell carci-
nomas (ROCs) are early lung cancers that are detected only by
sputum cytology, and are located mainly in the bronchial wall
(Saito et al. 1992). Non-treated ROCs develop into advanced lung,
cancers with radiolooically abnormal shadows (radiographically
non-occult squamous cell carcinomas: RNOCs) after several years
(Saito et al. 1990).
Accordingly. the ROC is thought to be a good model for the
purpose of elucidating the sequential genetic alterations in the
progression of lung cancer. In this study. we analyse allelic losses
on six chromosomes of40 cases ofROC and 40 ofRNOC.
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MATERIALS AND METHODS
Forty cases of resected ROCs and 40 cases of resected RNOCs
were examined. All cases were male. All cases ofROCs were clas-
sified as stage I. Resected specimens of ROCs were examined
pathologically by senial block sectioning (2 mm block thickness)
(Nagamoto et al. 1993). Depth and site of maximum invasion were
decided by histopathological analysis (Nagamoto et al. 1993).
ROCs were divided into two groups according to depth of inva-
sion: intrabronchial wall invasion (25 cases) and extrabronchial
wall invasion (15 cases). RNOCs were also divided into two
groups: stage 1(19 cases) and other stages (stage H-IV. 21 cases).
For RNOCs. tumours and corresponding normal tissues were
stored frozen at - 80'C until DNA extraction could be performed.
DNA was prepared by proteinase K digestion and phenol-chloro-
form extraction. For ROCs. eight20-gm-thick sections oftumours
and corresponding normal tissues were cut from formalin-fixed.
paraffin-embedded blocks. These eight sections were used for
microdissection according to the technique described elsewhere
(Sundaresan et al. 1992). DNA was obtained by proteinase K
digestion and phenol-chloroform extraction.
Polymorphic DNA markers used in this study were D2S116 on
2q33. D3S643 and D3S1298 on 3p21. D5S659 and L5.71 on 5q21.
D7S522 on 7q31. D9S1748 on 9p21 and TP53 on 17pl3. These
markers were obtained from GenBank (accessions except for
D9S1748 were Z16506. D01084. Z16860. Z24277. X78131.
Z17100. and X61505. respectively). Sequences of primers for
these markers were as follows: 5'-TGCTCATAATCCA-
CAAAAAT-3' and 5'-AAGGAGAAGAGGATTGGATT-3'
for D2S116; 5'-TCCAGGCTGGGTAACAGGAG-3' and
5'-ACAGAACTGCCAAACCATCC-3' for D3S643: 5'-GAGGT-
GCTAGGGCTCCAG-3' and 5'-TCCCCTGTGAAGCGTGTG-3'
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for D3S 1298; 5'-AATCCTCTGGTTGCTTTACA-3' and
5'-GATCCAATGAGGTTITAGGT-3' for D5S659; 5'-CAGCCCC-
ACAGGTCTTl-3' and 5'-TGGAGTGGCCGlTTCITIT-3' for
L5.71; 5'-GATTCGCATACTCCCACTTA-3' and 5'-TATGCCACT-
CCCICACACTG-3' for D7S522; 5'-CACCTCAGAAGTCAGT-
GAGT-3' and 5'-GTGCTTGAAATACACCITfCC-3' for D9S1748
(these sequences were obtaied from GDB: GDB I) GOO-595-589);
5'-CCCCATTCCCCITFICCTA-3' and 5'-ACrATTCAGCCC-
GAGGTGC-3' for TP53. One primer of each pair was end labelled
with [y3-'PATP (10 mCiml-1; DuPont New England Nuclear) by use
ofT4 polynucleotide kinase (Boehringer-Mannheim). PCR mixtures
in a volume of 15 l contained 100 ng ofgenoniic DNA, 1.5 pmol of
each primer, 15 pmol of each dNTP, 10 mm Tris-HCI (pH 8.0), 50
mM potassium chloride, 25 mM Magnesium chloide, 0.01% gelatin
and 0.2 units of Taq polymerase (Perkin-Elmer). PCR conditions
were 40 cycles of 95°C for 30s, 58°C for 30s, and 72°C for 30s.
PCR products were electr eed in 6% polyacrylamide gels
including 8 M urea and 32% formarnide, and then subjected to
autoradiography. When the signal intensity in tumour tissue was
<50% of that in normal tissue as judged by densitometric analysis
(Figure 1), the tumour was regarded as having allelic loss
(Thiberville et aL 1995b).
RESULTS
The allelotyping ofall 80 cases was shown in Table 1. The average
frequency ofLOH was 40%. The frequency ofLOH ofROCs and
RNOCs is shown inFigure 2. In all groups, 3p, 5q and 17p showed
frequent LOH. Moreover, allelic loss on 17p was more frequent in
RNOCs (70%) than in ROCs (49%). On the other hand, 2q, 7q and
9p showed loss less frequently in both ROCs and RNOCs.
The average fractional allelic loss (FAL) (Vogelstein et al, 1989)
of all cases, ROCs and RNOCs was 0.4, 0.39 and 0.42 respec-
tively. Ratio ofcases with FAL >0.5 increased gradually according
to cancer progression (Table 2). In ROCs with intrabronchial wall
invasion, six cases had LOH on only one locus, and six cases had
LOH on two loci. Of these six cases, four cases had loss on 3p2l
and any other locus, two cases had loss on 17pl3 and any other
locus, one case had loss on 3p21 and 17pl3.
Table 1 The alelotypig of all 80 cases analsed
_ a* . '* 'S - W '7 m_ iwu C. aq ' s*' 7ps ms nu a
1 - 0 C - O 0 41 0 0 0 - 0 O
2 * C C - 0 * 42 C * 0 0 0 -
3 O 0 0 - - 43 C O C - 0 O
4 - Q O * 44 0 C 0 - C C
5 0 0 0 0 0 0 45 0 0 * - O
6 O O O C - 0 46 0 0 S - - -
7 O - - - 0 - 47 0 O O 0 0
8 0 * * ) 0 0 48 0 0 0 - S -
9 - 0 0 - O - 49 - C 0 0 * ) 0
10 -0 0 0 so OO 0 0 - * n1 - 0 - - 0 o 51 0 O 0 0 0 -
12 0 0 O _ 0 52 C 0 - 13 0
13 0 0 * 0 0 0 53 0 0 -- C
14 C 0 0 0 C 0 54 0 * - -
15 0 0 as C 0 0 C - C
16 0 S * - C) 0 6 C - O - C)
17 0 0 * 0 0 0 57 0 0 C - *
1a 0 0 - 0 - 58 - 0 0 C -
19 0 0 0 - * 0 so 0 0 0 - *
20 0 C) * C C 60 0 S O - -
21 C 0 0 - C) * 61 - C) C 0 0 0
22 * 0 - - 0 * 0 0 C - C) -
23 - 0 - - S 63 0 O C 0 0 0
24 C 0 0 - C C 4 0 0 - 0 -
25 - 0 - C) - 0 65 0 0 C C) -
2 0 - - 0 a 0 0 - -
27 0 0 C) - 0 - 67 O S * - -
2B 0 0 - - 0 0 68 0 C .) - C -
2 0- 0 0 - C 0 66 - -
30 - 0 5 O 0 0 0 * 0 0 - C 0
31 0 * * 7- 0 O 0 - 0 0
32 C) 0 - 0 - 72 ) 0 * - *
33 0 0 5 - - * 73 - 0 o - -
34 0 0 - 0 * 74 0 0 0 - 0 0
3C 0 0 ** 75 0 0- - -
35 0 0 78 0 S S 0 -
3? * 0 0 - 0 C 77 0 * - 0 S
38 * - - - 78 0 0 0 0 *
3 o - C) 0 * 79 C 0 C 0 - 0
40 C o 0 - C 0 0 C s - _ _
Cases 1-25: intrabronca wa invasion ROC; cases 26-40, extrabroncha wall invasion ROC; cases 41-59: stage RNOC; cases60-80: stageIl-V RNOC;
open arde, retenbon of heterozygosly, closed arcle, koss ofheterozygosity - case notinformative; ROC, roentgenxxraphKalty occult bronchogenic squamous-
cell carcxna RNOC, roentgenorai non-occult squamous cel carcinoma.
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Table 2 Relationship between lung cancer progression and FAL
ROC RNOC
Intrabronchial wall invasion Extrabronchial wall invasion Stage I Stage IHV
CaseswithFAL>0.5 425(16^) 515 (33%) 619(32--c 1021 (48%c)
940 23l-) 1640(40-)
FAL. fractional allelic loss: ROC. radiographically occult bronchogenic squamous-cell carcinoma. RNOC. radiographically non-occult squamous-cell carcinoma:
which means advanced lung cancers with radiologically abnormal shadows.
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Figure 1 LOH n recresentati'e cases of ROCs. Eacn a-r-s nclcates ne
zcsition of tne deleted alleie N normaa tlssue: T tLmcur tissue: LOH css of
heterozygostv. ROC raadograpn callv occOlt broncongen c squamous-ce
carc noma
DISCUSSION
In order to elucidate sequential genetic changes in lung cancer. vve
analvs-ed the incidence of allelic losses on chromosome recions
'q . :p' l. -5q' 1. 7q31. 9p'1 and 17p 3of 40 cases of ROC and
40 cases of RNOC.
In lung cancers. allelic losses have been observed frequently on
3p2l ITsuchiva et al. 1992 . and novel tumour-suppre~sor genes
x-ere suggested on this locus iWei et al. 19961. Several groups
reported LOH on 3p21 in a fex- cases of dysplasia and carcinoma
in situ iCIS) of the lung iSundaresan et al. 1992: Chung et al.
1995: Hung et al. 1995: Thiberville et al. 1995fa. Our results
shoxxed a constant. high incidence ofallelic loss on 3p2 I in all four
groups Iintrabronchial mx asion. extrabronchial mnvasion. stace I
and other stages ). which suggests that LOH on this locus is related
to an early step in squamous cell lung cancer SQLC progression.
Frequent allelic losses on 5q 1 x ere reported in advanced
SQLCs Tsuchiva et al. 1992t. and one report .Showxed an
increasino incidence accordinc to tumour dexelopment
dxsplasia-CIS-microinvasix e Thiber -ille et al. 199-5 i.
Howxexer. the number of cases -studied x% as not enough to a.scertain
the statistical sicnificance of differences in incidence. Our present
studv shox-ed a constant. hich incidence of LOH on 5q2I in all
four groups. These results suggLeSt that LOH on 5q2 I is related to
an early step in SQLC progression
The TP53 polymorphic marker used in this present studv exists
on p53 tumour-suppressor gene locus. A frequent p53 aberration
xwas observed in many cancers including lung- cancers (Monica et
al. 1991 . Recentlv. some groups reported that LOH on 17pl3
occurred in dx splasia and CIS of the luno in a fexx cases Sozzi et
al. 1992: Sundaresan et al. 1992: Chung et al. 199-5. Our results
showxed a high frequencv of LOH on the p53 locus even in intra-
bronchial xwall invxasion of ROC. and the frequenc\ of LOH
so
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Figure 2 Incidence of LOH on six chromosomes. Incidence of LOH on six chromosomes classified by depth of invasion and pathological stage. Allelic losses
on 3p21. 5q21 and 17p13 occur frequently even in the intrabronchial wall invasion of ROCs. LOH. loss of heterozygosity. ROC. radiographically occult
bronchogenic squamous-cell carcinoma. *. Intrabronchial wall invasion ROC (25): 1 extabronchial wall invasion ROC (15): S. stage RNOC (19): 2. stage
II-IV RNOC (21)
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These data suggest that the p53 gene is related to an early step of
SQLC progression and also correlated with the depth of invasion.
Concerning this suggestion, positive immnunostaining of p53 was
observed to be significantly correlated with the depth of invasion
in colorectal cancer (leda et al, 1996).
Kohno et al (1994) reported that a homozygous deletion was
detected on chromosome 2q33 in a human small-cell lung
carcinoma cell line, and suggested the presence of a novel
tumour-suppressor gene there. The frequency of LOH on 2q in
several reports (Tsuchiya et al. 1992; Shiseki et al, 1994; Kohno
et al, 1994) ranged from zero to 63% in advanced lung cancers. Our
examination showed a constant, low frequency ofLOH on 2q33 in
tumour progression. Based on our results, we conclude that LOH
involving 2q33 is less important forSQLC progression.
LOH on 7q31 was seen frequently in head and neck squamous
cell carcinomas (Zenklusen etal, 1995). Someinvestigators reported
that 9p21 frequently showed LOH even in dysplasia and CIS ofthe
lung (Thiberville et al, 1995a). Others reported mutation ofp16 to
be more frequent in metastatic lesions than in primary lung cancers
(Okamoto et al, 1995). However, ourresults showed norelationship
between LOH on 7q31 or9p21 and SQLC progression.
The average FAL ofROCs was lower than that ofRNOCs, and
the ratio of cases with FAL >0.5 increased gradually according to
the degree of cancer progression. These results suggest an accu-
mulation of genetic alterations linked to SQLC progression.
Among six cases ofROC with intrabronchial wall invasion having
LOH on two loci, five cases had LOH on 3p2l or 17pl3 and only
one case hadLOH on 3p2l and 17pl3, which suggests that loss on
3p2l or 17pI3 plays an important role in lung cancer progression
and occurs at the early stage oftumorigenesis. It also suggests that
loci other than 3p2l or l7pl3 may also play an important role.
Systems other than LOH [methylation error (Merlo et al, 1995)
loss ofimprinting (Kondo et al, 1995), forexample]) may play an
important role in SQLC progression.
In summary, we analysed many cases of early and advanced
SQLCs, and presented evidence that genetic alterations on 3p2l.
5q21 and l7pl3 are related to the progression of SQLCs.
The alterations on 3p2l, 5q21 and l7pl3 occurred frequently
even in the stage of intrabrnchial wall invasion of ROCs, which
seems to be an early step of tumour progression. Moreover, an
allelic loss on 17pl3 isalsorelatedtothelate stageoftumorigenesis.
On the other hand, genetic changes on 2q33, 7q31 and 9p21 were
few and notrelatedtotheprogressionofSQLCs. In this study, mate-
rials were limited to SQLCs. The number ofcases studied was not
enough for a real statistical analysis. Further studies on many cases
ofpremalignant lesions are needed to determine more precisely the
sequential genetic changes in lung cancer progression.
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